// App-Quantinova.ai

P1694 : THROMBOSIS RISK ASSESSMENT IN LYMPHOMA PATIENTS - PROSPECTIVE PILOT SUDY

Researchers

Presenter

  • Darko Antic

Principal Investigators

  • Vladimir Otasevic

  • Natasa Milic

  • Vojin Vukovic

  • Biljana Mihaljevic

Medical Centers

  • Lymphoma Center,Clinic for Hematology, Univeristy Clinical Center of Serbia,Belgrade,Serbia

  • Institute for medical statistics and informatics,Faculty of Me

  • Clinic of Hematology ,Clinical Center of Serbia,Belgrade,Serbie Montenegro

  • Institute of Physiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

  • Institute for medical statistics and informatics,Faculty of Medicine, University of Belgrade,Belgrade,Serbie Montenegro

  • Lymphoma Center,Clini

  • Lymphoma Center,Clinic for Hematology, Univeristy Clinical Center of Serbia,Belgrade,Serbia

Locations

  • Serbia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • D-dimer

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved